🇺🇸 FDA
Pipeline program

PEG-somatropin

GenSci 004 CT-4

Approved mab active

Quick answer

PEG-somatropin for Growth Hormone Deficiency is a Approved program (mab) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
Growth Hormone Deficiency
Phase
Approved
Modality
mab
Status
active

Clinical trials